The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients-Reference-Cited by-同舟云学术

The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients

Published:2017-03-13 Issue:21 Volume:8 Page:34736-34749
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Schubert Claudia¹,Chatain Nicolas¹,Braunschweig Till²,Schemionek Mirle¹,Feldberg Kristina¹,Hoffmann Melanie¹,Dufva Olli³,Mustjoki Satu³,Brümmendorf Tim H.¹,Koschmieder Steffen¹

Affiliation:

1. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany

2. Institute of Pathology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany

3. Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twenty years of evolution of CML therapy: how the treatment goal is moving from disease to patient;Therapeutic Advances in Hematology;2023-01

2. Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms;Cells;2021-02-19

3. Fyn kinase mediates pro-inflammatory response in a mouse model of endotoxemia: Relevance to translational research;European Journal of Pharmacology;2020-08

4. Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling;Leukemia;2019-03-06